Politics

Psychedelic… win growing respect

MDMA has yet to break down legal barriers the way psilocybin has, probably because of suspicion about its origins in a laboratory rather than a natural source. But it’s winning greater acceptance. The same can be said of LSD, the best-known of psychedelic drugs. It, too, has won growing respect from users and professionals alike……

READ MORE
Science

Microdosing zebrafish… shows its potential benefits for humans

…repeatedly microdosed… zebrafish with LSD.… …using behavioural neuroscience tests to quantify locomotion, boldness and anxiety-like behaviour… we [also] found that zebrafish acutely dosed with the terpene limonene (found in citrus fruit peels and cannabis) and myrcene (found in cannabis and hops), showed a significant reduction in anxiety-like behaviour… [with terpene limonene & myrcene] no negative…

READ MORE
Anthropology

Missouri… proposes adding access to LSD, MDMA, peyote, and psilocybin as treatment options

HB 2429 would expand access for right-to-try to not only those with terminal illnesses but also those who are afflicted with debilitating or life-threatening conditions as well. Missouri has had its own version of right-to-try since 2014… “Eligible patient”…has a debilitating, life-threatening, or terminal illness… …proposal reads, “The offense of possession of more than ten grams but…

READ MORE
Science

Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers

This examination of a large international sample of adults highlights the prominence of therapeutic and wellness motivations for microdosing psychedelic drugs and identified lower levels of anxiety and depression among microdosers relative to controls.  Comparisons of psilocybin to LSD microdosers indicated no differences on measures of Depression, Anxiety and Stress from the DASS-21 (all values for F (1, 827) < 1.0, p > 0.50). The inclusion of…

READ MORE
Biography/Memoir

Patents for psychedelics…

…nearly every day, another psychedelics company announces its work in securing patents for the intellectual property represented by the product they developed… a quick search of the USPTO site shows that there are currently hundreds of patents related to LSD and Psilocybin products and formulations. Psilocybin (U.S. Patent No. 3,183,172, “Obtaining Psilocybin and Psilocin from…

READ MORE
Psychology

LSD vs. psilocybin microdosing for mental health and workplace productivity

[Case reports]: LSD… was better for more puzzle-like creativity – for solo pondering over a question or engaging in a writing task…. …[psilocybin] reminded me of what psychologists call the fundamental attribution error, or the tendency to attribute someone else’s poor performance to inherent defects in their personality but blame our own slip-ups on someone else.…

READ MORE
Biography/Memoir

What [happened on]… 550 doses of LSD?

The story of CB, a 49-year-old woman, and her roommate, who witnessed the event. CB had contracted Lyme disease in her early 20s, and by the LSD event, she experienced significant pain in her feet and ankles, routinely taking morphine for a decade… CB snorted… pure LSD – 550 times the normal recreational dosage of…

READ MORE
Biography/Memoir

What [happened]… 550 doses of LSD?

The story of CB, a 49-year-old woman, and her roommate, who witnessed the event. CB had contracted Lyme disease in her early 20s, and by the LSD event, she experienced significant pain in her feet and ankles, routinely taking morphine for a decade… CB snorted… pure LSD – 550 times the normal recreational dosage of…

READ MORE
Spirituality

LSD… benefits…

…there has been a huge uptake in LSD consumption. From 2015 to 2018, there was a 56 percent increase in overall LSD usage, a 70 percent increase for college graduates, a 59 percent increase for people aged 26 to 34 and a whopping 223 percent for people aged 35 to 49.  Mental health issues like…

READ MORE
Science

Shrooms and lsd linked to lower heart disease and diabetes risk

“The findings suggest that lifetime classic psychedelic use is associated with lower odds of having had heart disease or diabetes in the past year,” lead study author and Oxford sociologist Otto Simonsson, [said]. A team of scientists identified the unexpected trend after poring over ten years’ worth of data from the National Survey on Drug…

READ MORE